10-Q Filing

Company

Alzamend Neuro, Inc.

Filed

December 9, 2025

Period of Report

October 31, 2025

Accession Number

0001214659-25-017793

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →